Graves' Disease and Graft-versus-Host Disease: Pipeline Therapeutics Update
Several companies are actively developing novel therapies for Graves' Disease, targeting mechanisms like IGF-1R and FcRn.
Several companies are actively developing novel therapies for Graves' Disease, targeting mechanisms like IGF-1R and FcRn.